Cargando…

Feasibility of tumor-derived exosome enrichment in the onco-hematology leukemic model of chronic myeloid leukemia

Due to the discovery of their role in intra-cellular communications, exosomes, which carry information specific to the cell of origin, have garnered considerable attention in cancer research. Moreover, there is evidence to suggest the possibility of isolating different exosome sub-populations based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernardi, Simona, Foroni, Chiara, Zanaglio, Camilla, Re, Federica, Polverelli, Nicola, Turra, Alessandro, Morello, Enrico, Farina, Mirko, Cattina, Federica, Gandolfi, Lisa, Zollner, Tatiana, Buttini, Eugenia Accorsi, Malagola, Michele, Russo, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844640/ https://www.ncbi.nlm.nih.gov/pubmed/31638195 http://dx.doi.org/10.3892/ijmm.2019.4372

Ejemplares similares

Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case?
por: Farina, Mirko, et al.
Publicado: (2020)

RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients?
por: Zanaglio, Camilla, et al.
Publicado: (2020)

ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial
por: Bernardi, Simona, et al.
Publicado: (2020)

Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection
por: Bernardi, Simona, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit
por: Malagola, Michele, et al.
Publicado: (2020)

Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol)
por: Malagola, Michele, et al.
Publicado: (2022)

Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner?
por: Malagola, M., et al.
Publicado: (2019)

Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia
por: Malagola, Michele, et al.
Publicado: (2023)

High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review
por: Accorsi Buttini, Eugenia, et al.
Publicado: (2023)

Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2)
por: Morello, Enrico, et al.
Publicado: (2022)

Advances in CMV Management: A Single Center Real-Life Experience
por: Malagola, Michele, et al.
Publicado: (2020)

PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA
por: Accorsi Buttini, E., et al.
Publicado: (2022)

dsDNA from extracellular vesicles (EVs) in adult AML
por: Bernardi, Simona, et al.
Publicado: (2020)

Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients
por: Farina, Mirko, et al.
Publicado: (2022)

PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY
por: Bernardi, Simona, et al.
Publicado: (2023)

Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis
por: Farina, Mirko, et al.
Publicado: (2021)

P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY.
por: Farina, M., et al.
Publicado: (2022)

Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation
por: Skert, Cristina, et al.
Publicado: (2017)

Health Related Quality of Life in Patients with Onco-hematological Diseases
por: La Nasa, Giorgio, et al.
Publicado: (2020)

A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation
por: Morello, Enrico, et al.
Publicado: (2021)

Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR)
por: Abruzzese, Elisabetta, et al.
Publicado: (2023)

Bacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre Experience
por: Malagola, Michele, et al.
Publicado: (2017)

CMV Management with Specific Immunoglobulins: A Multicentric Retrospective Analysis on 92 Allotransplanted Patients
por: Malagola, Michele, et al.
Publicado: (2019)

How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation
por: Polverelli, Nicola, et al.
Publicado: (2022)

Surgical Management of Rhinosinusitis in Onco-Hematological Patients
por: Di Girolamo, Stefano, et al.
Publicado: (2014)

Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)
por: Russo, Domenico, et al.
Publicado: (2021)

Emerging innovations on exosome-based onco-therapeutics
por: Dai, Xiaofeng, et al.
Publicado: (2022)

Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?
por: Mouawad, Nayla, et al.
Publicado: (2023)

Glucocorticoids and Antivirals for HBV Reactivation in Onco-Hematologic Patients.
por: Marzano, Alfredo, et al.
Publicado: (2010)

Two cases of paralitic ileus in onco-hematologic patients
por: Carraro, Francesca, et al.
Publicado: (2012)

Safety of switching between rituximab biosimilars in onco-hematology
por: Urru, Silvana A. M., et al.
Publicado: (2021)

Editorial: Real-World evidence in onco-hematological patients
por: Vener, Claudia, et al.
Publicado: (2022)

Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor
por: Cattina, Federica, et al.
Publicado: (2017)

Top-ten infections in onco-hematological patients (2015-2017)
por: Camps, Isabel Ruiz, et al.
Publicado: (2019)

Reporting reimbursement price decisions for onco-hematology drugs in Spain
por: Elvira, David, et al.
Publicado: (2023)

Exosomes and Extracellular Vesicles in Myeloid Neoplasia: The Multiple and Complex Roles Played by These “Magic Bullets”
por: Bernardi, Simona, et al.
Publicado: (2021)

Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology
por: Crisci, Stefania, et al.
Publicado: (2019)

The profile of the onco-hematology patient in the palliative care: 4 years of experience
por: Couto, Maria Eduarda, et al.
Publicado: (2019)

Pediatric onco-hematological home care during COVID-19 pandemic
por: Amicucci, Matteo, et al.
Publicado: (2021)

Editorial: Digital health and real-world evidence in onco-hematological patients
por: Vener, Claudia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kmbgs1h69stgilisbq01u0kgc5